Showing results (111-120 of 139) with videos related to
Sort By:
Pageof 14
Journal of Cardiovascular Echography|March 15, 2024
Constrictive Pericarditis: An Update on Noninvasive Multimodal DiagnosisDavide Restelli, Maria Ludovica Carerj, Gianluca Di Bella, et al.Journal of Nuclear Medicine Technology|October 4, 2022
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive ReviewEmran Askari, Soroush Zarehparvar Moghadam, Damian Wild, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2020
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practiceVikas Prasad, Raj Srirajaskanthan, Christos Toumpanakis, et al.Prostate Cancer and Prostatic Diseases|May 20, 2021
The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patientsMatteo Bauckneht, Francesco Bertagna, Maria Isabella Donegani, et al.The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 17, 2020
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics studyPierpaolo Alongi, Riccardo Laudicella, Alessandro Stefano, et al.Diagnostics (Basel, Switzerland)|April 23, 2022
Radiomics Analysis of Brain [18F]FDG PET/CT to Predict Alzheimer's Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning AnalysisPierpaolo Alongi, Riccardo Laudicella, Francesco Panasiti, et al.Oncotarget|May 1, 2018
Undetectable or low (<1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patientsAlfredo Campennì, Luca Giovanella, Salvatore Antonio Pignata, et al.British Journal of Cancer|January 9, 2025
Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE studyJoe M O'Sullivan, Daniel Heinrich, Elena Castro, et al.Cancers|February 25, 2022
[68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The "Theragnomics" ConceptRiccardo Laudicella, Albert Comelli, Virginia Liberini, et al.European Radiology Experimental|June 14, 2022
Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnosticsVirginia Liberini, Riccardo Laudicella, Michele Balma, et al.Pageof 14